Eva Pisa
Net worth: 217 784 $ as of 2026-05-30
Net worth: 217 784 $ as of 2026-05-30
Eva Pisa is currently a Member of the Supervisory Board at QIAGEN NV since 2022.
Formerly, Dr. Pisa was Chief Executive Officer at Cepheid AB from 2001 to 2007 and SVP-Roche Centralized & POC Solutions at Roche Diagnostics International AG from 2007 to 2020.
Education includes a doctorate from Karolinska Institutet and an MBA from Heriot-Watt University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-27 | 5,952 ( 0% ) | 217 784 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| QIAGEN N.V. | Director/Board Member | 2022-06-22 |
| Companies | Position | End |
|---|---|---|
Roche Diagnostics International AG
Roche Diagnostics International AG Medical SpecialtiesHealth Technology Manufactures and supplies diagnostics systems | Corporate Officer/Principal | 2019-12-31 |
Cepheid AB
Cepheid AB Medical/Nursing ServicesHealth Services Develops and provides molecular diagnostic testing | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heriot-Watt University
Heriot-Watt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cepheid AB
Cepheid AB Medical/Nursing ServicesHealth Services Develops and provides molecular diagnostic testing | Health Services |
Roche Diagnostics International AG
Roche Diagnostics International AG Medical SpecialtiesHealth Technology Manufactures and supplies diagnostics systems | Health Technology |
Select your edition
All financial news and data tailored to specific country editions